This topic contains a solution. Click here to go to the answer

Author Question: When developing a quality improvement program, what is the most important aspect of the program that ... (Read 83 times)

piesebel

  • Hero Member
  • *****
  • Posts: 565
When developing a quality improvement program, what is the most important aspect of the program that should be considered?
 
  a. Vision and values of the agency
  b. Standards used to provide care
  c. Results of nursing care
  d. Evaluation of process changes

Question 2

A quality assurance manager does an audit and six months later returns to see if the problem has been eliminated. This step
 
  a. Involves selecting explicit criteria for quality care
  b. Includes the review of records
  c. Requires a peer review of all cases that do not meet criteria
  d. Completes the audit process



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bblaney

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

ANS: C

Answer to Question 2

ANS: D




piesebel

  • Member
  • Posts: 565
Reply 2 on: Jul 8, 2018
Thanks for the timely response, appreciate it


Chelseyj.hasty

  • Member
  • Posts: 319
Reply 3 on: Yesterday
Excellent

 

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library